Speaker:Han, Ge Date:13 May 2014 Introduction to The Alzheimer’s Disease Related Genes.

Slides:



Advertisements
Similar presentations
Department of Neurology, Mayo Clinic Arizona
Advertisements

Alzheimer’s Disease Edwin Onattu P. 3.
Etiopathogenesis of Alzheimer's disease
ALZHEIMER’S DISEASE Erin Dancey. Overview Alzheimer’s is the most common cause of dementia in adult life and is associated with the selective damage of.
Disorders with Complex Genetics DCGs. Signs & Symptoms: Memory loss for recent events Progresses into dementia  almost total memory loss Inability to.
Genetic Screening for Alzheimer’s Disease Thorstensen: Genetic Screening for Alzheimer's Disease 1.
ALZHEIMER'S DISEASE (AD)
CSF tau Is it an informative biomarker of AD pathology Chris Clark Alzheimer’s Disease Center University of Pennsylvania.
Sorting Through the Tangles: Alzheimer’s Disease
Alzheimer’s Disease Find group of ~4 students ~ 10 minutes Discuss the following personal family connection to AD (if willing only) observations/experiences.
ALZHEIMER’S AND DOWN’S SYNDROME
Alzheimer’s Disease: Genetics, Pathogenesis, Models, and Experimental Therapeutics.
Aging, Memory and Alzheimer’s Disease Kinga Szigeti, MD, PhD.
Methods of Studying the Brain Mrs. Joseph AP Psychology Solon High School.
Dr. Amr Moustafa Biochemistry Unit Department of Pathology.
PET/CT & PET/MRI Radiopharmacy
A view into Neurodegeneration and neurodegenerative diseases Bahareh Eftekharzadeh Laboratory of Dr. Xavier Salvatella SemesterI Crazy about Biomedicine.
There are currently 26 million people worldwide with Alzheimer’s disease. This figure is projected to grow to more than 106 million people by 2050.
Edward Kaye 1,2, Kie Honjo 3,4, Ana Petrovic-Poljak 5, Robert van Reekum 6, David Streiner 1,6,7,8,9, Alan Wilson 6,10, Sandra Black 3,4,11, Morris Freedman.
Nuclear Medicine. The History Henri Becquerel 1896-Discovered mysterious “rays” Nobel Prize Marie Curie named mysterious rays “radioactivity”
ALZHEIMER’S DISEASE BY OLUFOLAKUNMI KEHINDE PRE-MD 1.
Nature may have the answers for Alzheimer’s disease Sungkwon Chung Dept. of Physiology Sungkyunkwan University School of Medicine.
COST CM1103 Training School Structure-based drug design for diagnosis and treatment of neurological diseases Istanbul, 9-13 Sept 2013 Mirjana Babić, mag.biol.mol.
Disorders with Complex Genetics. Signs & Symptoms: Memory loss for recent events Progresses into dementia  almost total memory loss Inability to converse,
WHAT DO YOU REMEMBER ABOUT ALZHEIMER’S DEMENTIA?.
Introduction Alzheimer’s disease (AD) is a neurodegenerative disease associated with brain shrinkage and the loss of neurons, particularly cholinergic.
Alzheimer’s Disease -> The Disease of Darkness Varun Doshi.
PATHOLOGIC AGGREGATION OF THE BRAIN PROTEIN  -SYNUCLEIN CAUSES CELL DEATH IN PARKINSON AND ALZHEIMER DISEASE, Wenbo Zhou, PhD and Curt R. Freed, MD Division.
Molecular mechanism for Alzheimer’s disease : searching for the possible therapeutic targets Sungkwon Chung Dept. of Physiology Sungkyunkwan Univ. School.
Dr. Usman Ghani CNS Block.  Pathophysiology of alzheimer’s disease: 5I.
Brain Research Methods.
National Institute on Aging
Dr. Sigal fleisher-Berkovich Neuroinflammation is regulated by angiotensin related drugs: possible implications for neurodegenerative diseases.
Mason A. Israel et. al. Nature 2012
Molecular Imaging & Positron Emission Tomography Nicholas Mulhern BME 281.
Epidemiology of Alzheimer’s Disease
Nuclear Chemistry: The Heart of Matter. 2 Radioisotopes Radioactive decay Radioactive decay – Many isotopes are unstable – Many isotopes are unstable.
Under the supervision of miklós jászberényi
Alzheimer’s Disease Today and Tomorrow First case reported in 1906 Reported by Alois Alzheimer Patient Augusta D. first treated at 46 years old Paranoia,
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
1 Dr.Wael Mansy, Ph.D. Department of Clinical Pharmacy College of Pharmacy / King Saud University.
Genetic aspects of Alzheimer disease Karolina Pesz, Błażej Misiak, Maria M. Sasiadek Department of Genetics Wroclaw Medical University, Poland.
Alzheimer’s Disease (AD)
Positron Emission Tomography.
Alzheimer’s Disease and Cholesterol
How can we study the brain?
The Legal Implications of Detecting Alzheimer’s Disease Earlier
P.E.T. Positron Emission Tomography
Syed H. Omar, Christopher J. Scott, Adam S. Hamlin, Hassan K. Obied 
Aging in the CNS.
Learning Objectives By the end of this lesson you should…
Alzheimer’s Disease Dr. Usman Ghani CNS Block.
Alzheimer’s Disease CNS Block.
Imaging AD Progression Amyloid Imaging Agents.
Alzheimer’s Disease 1 in 9 people in the US aged 65 and older
Alzheimer Disease Mayo Clinic Proceedings
Q: How can we prevent or treat Alzheimer’s Disease?
Amyloid Imaging for Alzheimer's Disease in Practice
Disorders with Complex Genetics
Positron Emission tomography
The Role of Apolipoprotein E in Alzheimer's Disease
Elucidating the Role of TREM2 in Alzheimer’s Disease
Technician’s Notes Activity 10S Software Based 'Bubble chamber photographs'
Alzheimer Mechanisms and Therapeutic Strategies
Columbia University Medical Center
Alzheimer’s Disease Dr. Usman Ghani Neuropsychiatry Block.
Chapter 18 Dietary Phytochemicals in Neurodegenerative Disease
Robert W. Mahley, Yadong Huang  Neuron 
Fig. 2. Correlation between Aβ42 and Aβ40 levels in iNPH, AD, and CN subjects. The scatter plot shows the correlation between Aβ42 and Aβ40 levels. Representative.
Detecting and Diagnosing Alzheimer’s Disease
Presentation transcript:

Speaker:Han, Ge Date:13 May 2014 Introduction to The Alzheimer’s Disease Related Genes

2 Table of Content §1 Introduction §2 The Alzheimer’s Disease related genes §3 Three FDA approved agents for Imaging of Aβ Plaques §4 Summary

3 Discovery who: Dr.Allos Alzheimer(German psychiatrist) when:1906 Classification  Familial Alzheimer’s disease (FAD)  Sporadical Alzheimer’s disease (SAD) Dr.Alois Alzheimer (1864~1915) Auguste Deter (the first person diagnosed with AD) Discovery and Classification

4 Actual and estimated number of new Alzheimer disease cases in the US through the year 2050 Mount, C.Downton, C. Nat. Med. 2006, 12, 780 Growth in the number of AD AD is estimated to have cost the world $604 billion in 2010 alone. These costs are staggering, particularly in light of predictions that the worldwide number of AD cases, currently estimated at 36 million, will triple by 2050.

The hallmarks of AD Alzheimer's disease brain comparison Amyloid plaques and neurofibrillary tangles 5

6 The Alzheimer’s Disease related genes

7 Alzheimer’s Disease is a genetically complex disease. Familial Alzheimer’s disease related genes :APP 、 Presenilin1 and Presenilin 2... Sporadical Alzheimer’s disease related gene :APOE4… zh.wikipedia.org/zh-cn/ AD related genes

Henry W. Querfurth, Frank M. LaFerla, N. Engl.J.Med. 2010; 362: Two pathways exist for the processing of APP, one being nonamyloidogenic whilst the other pathway is amyloidogenic. 8 N-terminal APP enzymolysis pathways

9 Formation of amyloid fibril Schematic representation of amyloid fibril David J. Hayne, SinChun Lim and Paul S. Donnelly.Chem.Soc.Rev.2014;

10 3D structure of Aβ42 fibrils Structural studies using fibrils formed from Aβ 42 peptides have given insight into the 3D structure of Aβ 42 fibrils. David J. Hayne, SinChun Lim and Paul S. Donnelly.Chem. Soc. Rev.2014;

11 Presenilin(PS ) Presenilin transmembrane structure diagram PS-1PS-2 顾拥军,孙凤艳, J.Life Science,1997;5,9 extracellular intracellular HL-VI PS-1:70%~80% of FAD is related to the mutations in PS-1.(age of onset:40~50) PS-2:Some of FAD is related to the mutations in PS-2.(age of onset:50~60) The exact three-dimensional structure and function of PS remain unkonwn.

12 APOE ApoE4 in AD Pathogenesis Yadong Huang,Lennart Mucke.J.Cell.2012 , The apoE proteolysis hypothesis suggests that, in response to stress or injuries, neuronal apoE expression is triggered to facilitate neuronal repair. However, neuronal apoE undergoes proteolytic cleavage, with apoE4 being more susceptible to the cleavage than apoE3, resulting in the formation of neurotoxic fragments. The apoE4 fragments enter the cytosol and cause mitochondrial impairment and cytoskeletal disruption.

13 Analysis pipeline The information of AD ralated genes contain: genesymbol 、 geneID 、 ensembl ID proteinID 、 ensembl ID2Chromosomeinfo map to the chromosome

14 Preliminary data processing TGM6 、 SNAR-I 、 STK11 、 CLMN 、 UTS2D 、 PGAM5P1 、 ITGA1 、 OSTNIL1-RAP 、 LEMD2 、 VSNL1 、 Sec11C 、 PPP1R3B 、 SLC28A1 、 MPP7 、 CAMK4 、 CACNA1G 、 ARHGAP20 、 RELN 、 PCDH11X 、 LIPC 、 RP11-341A22.2 、 PRRC2C 、 PPP1R37 、 RFC3 、 HRK 、 MS4A4A 、 MS4A4E 、 TREM 、 BIN1 、 SAP30L 、 PVRL2 、 EDIL3 、 MEGF10 、 CD2AP 、 CDON 、 FAM113B 、 ARID1B 、 ELMO1 、 VLDLR 、 MMP12 、 ANKRD55 、 ANO4 、 GAB2 、 ITGA6 、 FMN2 、 ZNF592 、 APOE 、 BCHE 、 ZNF224 、 MSRA 、 CRADD 、 ST18 、 GEMC1 、 SLC9A9 、 AFF1 、 BCAS3 、 DISC1 、 PIK3R1 、 NKAIN2 、 CCDC50 、 ALPK3 、 DCHS2 、 FLJ45256 、 AC 、 FLJ33630 、 STK24 、 PAX2 、 CCDC134 、 STK32B 、 RP11-572M11.4 、 KCNV2 、 HECW1 、 VAT1L 、 TOMM40 、 RP J9.2 、 SP6 、 MRPL10 、 OSBPL7 、 GPC6 、 ADAMTS9 、 EPHA1 、 CSMD1 、 TREM2 、 POLN 、 SLC4A8 、 ATXN7L1 、 SORL1 、 MIR1275 、 MIR1275 、 PPAPDC1A 、 GABRG3 、 PICALM 、 CLU 、 APOC1 、 PDE7B 、 NUAK1 、 PARVB 、 SASH1 、 ZNF320 、 RIMBP2 、 EFNA5 、 MAN2A1 、 DMXL1 、 MOBP 、 FRMD4A 、 LOC 、 LOC 、 MYO16 、 MTHFD1L 、 DIP2C 、 NCS1 、 CYCS 、 LIMS2 、 CNTNAP2 、 AC 、 LOC 、 C12orf75 、 CR1 、 FLJ37543 、 GRIN3B 、 BZW2 、 TSPAN13 、 TSPAN13 、 EFR3A 、 RP11-242G20.2 、 TTLL7 、 MLN 、 NCR2 、 MS4A6A 、 LUZP2 、 CUGBP2 、 HMHA1 、 PCNX 、 SPON1 、 RRAS2 、 CEACAM16 、 CTNNA2 、 AC 、 NFIB 、 PLEKHG1 、 EXOC4 、 RNFT2 、 SLC4A1AP 、 BCL3 、 AC 、 MS4A 、 MMP3 、 AP 、 PSMA1 、 SLC2A9 、 CD33 、 GLIS3 、 EPC2 The AD related genes (GWASstudies) Number:153

15 Gene frequency statistics Frequency in GWASstudiesGenes 20APOE 13TOMM40 7BIN1 6PVRL2 4 PICALM 、 CLU 、 APOC1 3CR1 2 SLC2A9 、 CD33 、 GLIS3 、 EPC2 1 POLN 、 MS4A 、 PAX2 、 TREM2 、 MLN…(140) APOE 、 TOMM40 、 APOC1: Genes locate on the chromosome 19. TREM2: Some other studies have found that the mutation of TREM2 could increase the risk of AD.

16 1.Chromosome 19 has 14 AD ralated genes. Gene location on chromosome APOE 2.Chromosome 6, 5 and 11 also have 13,10,9 AD related genes respectively. So if there are genes like APOE locate on them? 3.Chromosome 21 has no AD related genes on it,but APP is on it. And Why?

17 Three FDA approved agents for Imaging of Aβ Plaques

18 (1) Amyvid(Diaryl alkene analogs) Company : Eli Lilly Year : (2) Vizaml(Planar heteroaromatic analogs) Company:General Electric Company Year: (3) Company:Pfizer Year: Florbetaben(Diaryl alkene analogs) They are just the agents to detect and specific binding to Aβ,not the drugs to treat or alleviate AD symptoms. The information of the 3 agents N. S. Mason, C. A. Mathis and W. E. Klunk, J. LabelledCompd. Radiopharm., 2013, 56, 89.

19 PET(Positron emission tomography, 正电 子发射计算机断层扫描 ) is a non-invasive molecular imaging technique that relies on the detection of radioactivity emitted from a positron-emitting isotope that is incorporated into a molecular tracer or imaging agent. The emitted positron annihilates releasing two gamma photons travelling in opposite directions. Detection of the emitted photons allows the generation of an image with a spatial resolution of 3–5 mm with high sensitivity. PET

20 Axial slices of Vizaml scans are shown for 2 representative subjects, cognitively normal control with low tracer retention (top) and AD patient with high tracer retention in cortex relative to cerebellum, reflecting widespread fibrillar amyloid (bottom). Landau SM,Breault C,Joshi AD,Pontecorvi M,Mathis CA,Jagust WJ,Mintun MA,J Nucl Med,2013;54:70-7. The image of PET

21 Summary  The full details of the role Aβ plaques, APOE, PS-1, and PS-2 play in congnitive impair in Alzheimer’s Disease remain a mystery.  The development of these agents for imaging of Aβ plaques might provide the means for early non-invasive detection of Aβ plaques in AD and pre-AD subjects.  AD ralated genes are abundant at chromosome 19. Maybe there are genes like APOE locate on chromosome 6,5 and 11.

22 Acknowledge Prof. Wu Prof. Ye Xudong Zou Yang Wang ……

23 Thank you for your attention!